Aretz M, et al. 2020 |
Characteristics and Outcomes of 21 Critically Ill
Patients With COVID-19 in Washington State |
10.1001/jama.2020.4326 |
Yes |
COPD: 7 (33.3%) |
Yes |
2 (9.1%) |
21 |
Bhatraju PK, et al. 2020 |
Covid-19 in Critically Ill Patients
in the Seattle Region — Case Series |
10.1056/NEJMoa2004500 |
Yes |
COPD: 1 (4%) |
Yes |
3 (12.5%) |
24 |
Chao JY, et al. 2020 |
Clinical Characteristics and Outcomes of
Hospitalized and Critically Ill Children and Adolescents with
Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical
Center in New York City |
10.1016/j.jpeds.2020.05.006 |
No |
- |
Yes |
11 (24.4%) |
46 |
Duanmu Y, et al. 2020 |
Characteristics of Emergency Department Patients
With COVID-19 at a Single Site in Northern California: Clinical
Observations and Public Health Implications |
10.1111/acem.14003 |
Yes |
COPD: 1 (10%) |
Yes |
10 (10%) |
100 |
Fan J, et al. 2020 |
The epidemiology of reverse transmission of
COVID-19 in Gansu Province, China. |
10.1016/j.tmaid.2020.101741 |
Yes |
COPD: N/A |
Yes |
N/A |
37 |
Ferguson J, et al. 2020 |
Characteristics and Outcomes of Coronavirus
Disease Patients under Nonsurge Conditions, Northern California, USA,
March-April 2020 |
10.3201/eid2608.201776 |
Yes |
COPD: 10 (13.9%) same
patients with asthma |
Yes |
10 (13.9%) |
72 |
Fernandéz R, et al. 2020 |
COVID-19 in Solid Organ Transplant
Recipients: A Single-Center Case Series From Spain |
10.1111/ajt.15929 |
No |
- |
Yes |
1 (5.55%) |
18 |
Gold JAW, et al. 2020 |
Characteristics and Clinical Outcomes of Adult
Patients Hospitalized With COVID-19 - Georgia, March 2020 |
10.15585/mmwr.mm6918e1 |
Yes |
COPD: 16 (5.2%) |
Yes |
32 (10.5%) |
305 |
Lechien JR, et al. 2020 |
Clinical and Epidemiological Characteristics
of 1,420 European Patients With Mild-To-Moderate Coronavirus
Disease 2019
|
10.1111/joim.13089 |
Yes |
Respiratory insufficiency 10
(0.7%) |
Yes |
93 (6.5%) |
1420 |
Li X, et al. 2020 |
Risk factors for severity and mortality in adult
COVID-19 inpatients in Wuhan |
10.1016/j.jaci.2020.04.006 |
Yes |
COPD: 17 (3.1%) |
Yes |
5 (0.9%) |
548 |
Merza MA, et al. 2020 |
COVID-19 outbreak in Iraqi Kurdistan:
The first report characterizing epidemiological, clinical, laboratory,
and radiological findings of the disease. |
10.1016/j.dsx.2020.04.047 |
Yes |
Bronchitis: 2 (13.3%) same patients with asthma |
Yes |
2
(13.3%) |
15 |
Richardson S, et al. 2020 |
Presenting Characteristics, Comorbidities,
and Outcomes Among 5700 Patients Hospitalized With COVID-19 in
the New York City Area. |
10.1001/jama.2020.6775 |
Yes |
COPD: 287
(5.4%) |
Yes |
479 (9%) |
5700 |
Sultan I, et al. 2020 |
The Role of Extracorporeal Life Support for
Patients With COVID-19: Preliminary Results From a Statewide Experience |
10.1111/jocs.14583 |
No |
- |
Yes |
N/A |
10 |
Wang X, et al. 2020 |
Nosocomial Outbreak of 2019 Novel
Coronavirus Pneumonia in Wuhan, China |
10.1183/13993003.00544-2020 |
No |
- |
Yes |
2 (5.7%) |
35 |
Yao Q, et al. 2020 |
Retrospective Study of Risk Factors for Severe
SARS-Cov-2 Infections in Hospitalized Adult Patients |
10.20452/pamw.15312 |
Yes |
Pulmonary disease (bronchiectasis, COPD or
asthma): 3 (2.8%) |
Yes |
3 (2.8%) same patients with other pulmonary
diseases |
108 |
Zhang JJ, et al. 2020 |
Clinical characteristics of 140 patients
infected with SARS-CoV-2 in Wuhan, China |
10.1111/all.14238 |
Yes |
COPD: 2 (1.4%) |
Yes |
0 |
140 |
Zhang L, et al. 2020 |
Clinical Characteristics of
COVID-19-infected Cancer Patients: A Retrospective Case Study
in Three Hospitals Within Wuhan, China |
10.1016/j.annonc.2020.03.296 |
Yes |
COPD: 1 (3.5%) same patient with asthma |
Yes |
1 (3.5%) |
28 |
Zhou X, et al. 2020 |
Clinical Characteristics of Coronavirus
Disease 2019 (COVID-19) Patients With Hypertension on Renin-Angiotensin
System Inhibitors |
10.1080/10641963.2020.1764018 |
Yes |
COPD:3 (2.7%) |
Yes |
1 (0.9%) |
110 |